|
 |
| home > pmps > spring 2004 > pharmaceutical counterfeiting ?° predicting the future |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
It is always difficult to predict the future; were it easy I would make a living from sitting at home playing the lottery. However, if we cannot accurately predict what is around the corner then we can make educated assessments of what is likely to happen. Investigating counterfeit pharmaceuticals is very much an intelligence-based pursuit. In the intelligence world, the analysis of patterns of activity and the following of trends are powerful weapons. Long-term studies of activity and the accurate analysis of information gleaned can be of great value, particularly when planning strategies to combat such activity. These skills can be transferred to the commercial world and specifically in this case to the pharmaceutical industry. Thus we are able, theoretically at least, to gain an insight into the aims of the counterfeiter.
There are massive threats associated with pharmaceutical counterfeiting. It should be borne in mind that this is a truly global activity, which is in many cases life threatening. Statistics show that there is a gradual and constant increase in pharmaceutical counterfeiting, and recent events reveal that this activity is no longer confined to less developed countries. In the UK, Western Europe and the US we are fortunate in that we have responsible and reactive monitoring and regulatory agencies, which respond rapidly to all cases of illegal pharmaceuticals.
However, it is becoming more of a problem in the Western world and we cannot afford to become complacent. Less developed countries are not so fortunate in that they have no efficient methods of detecting counterfeit pharmaceuticals and the agencies responsible are under-funded or prone to corruption. It is ironic that the countries which are least capable of fighting this battle are those with the greatest problems. |
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
Clinical Trials in Latin America
9-10 September 2010, Lima, Peru
CBI’s Conference on Clinical Trials in Latin America, being held 9–10th September 2010 in Lima, Peru brings together key stakeholders involved with clinical trials in Latin America. Latin America is an increasingly desirable location for running clinical trials, and it is important for those involved to collaborate with colleagues and industry counterparts regarding the challenges of developing, executing and completing clinical trials in Latin America. This is a unique opportunity for pharmaceutical executives in Latin America to hear from key regulatory officials, pharmaceutical leaders, CROs and sites on how all stakeholders in the clinical process can ultimately achieve desired results.
More info >> |
|
 |
News and Press Releases |
 |
PharmaBrand Summit 2010
Top pharmaceutical executives shared best practices at the PharmaBrand Summit
2010, which took place on the 21st to 23rd June 2010 in Monte-Carlo, Monaco
and was organised by Marcus Evans
More info >> |
|
 |
